Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Head & Neck 1

Conditions

Neoplasms 5Pain 3Cachexia 3Breast Neoplasms 3Trigger Finger Disorder 2Prostatic Neoplasms 2Lymphoma, Follicular 2Lung Neoplasms 2Inflammation 2Ganglion Cysts 2De Quervain Disease 2Colorectal Neoplasms 2Weight Loss 1Uveal Melanoma 1Uterine Cervical Neoplasms 1Supratentorial Brain Tumor 1Stomach Neoplasms 1Rectal Neoplasms 1Prostatitis 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pleural Effusion, Malignant 1Pituitary Neoplasms 1Patient Satisfaction 1Pancreatic Neoplasms 1Oropharyngeal Neoplasms 1Nose Neoplasms 1Neoplasm Metastasis 1Mucositis 1Menorrhagia 1

Interventions

oxycodone-acetaminophen 1cyclohexaneacetic acid 1acetaminophen, hydrocodone drug combination 1Tomography, Emission-Computed, Single-Photon 1Pain Management 1Methods 1Ibuprofen 1Gabapentin 1Fentanyl 1Educational Status 1Early Intervention, Educational 1Analgesia 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Abnormalities, Radiation-Induced × Ibuprofen × Clear all
NCT02480114 2021-02-18

Gabapentin Compared to Standard of Care in Preventing Mucositis in Patients With Stage III-IV Head and Neck Cancer Undergoing Primary or Adjuvant Chemoradiation Therapy

Vanderbilt-Ingram Cancer Center

Phase 3 Completed
79 enrolled 8 charts
Head & NeckOther

Abnormalities, Radiation-Induced, Head and Neck Neoplasms, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡